Margaret, T., Sunil, H., Lei, Z., Michele, R., Andrew, H., Michel, D., . . . Eric, V. C. (2016). P-288 Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine. Ann Oncol.
Citação norma ChicagoMargaret, Tempero, et al. "P-288 Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus Nab-Paclitaxel and Gemcitabine Vs. Placebo Plus Nab-Paclitaxel and Gemcitabine." Ann Oncol 2016.
Citação norma MLAMargaret, Tempero, et al. "P-288 Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus Nab-Paclitaxel and Gemcitabine Vs. Placebo Plus Nab-Paclitaxel and Gemcitabine." Ann Oncol 2016.